Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was the largest biotechnology company in Washington State. At the end of that year, Amgen acquired the company for $16 billion.
See the "What's Made Us Immunex" book for a more complete history.
This collection documents the public face of Immunex from its founding to its merger with Amgen. Donations were restricted to items in the public domain; therefore it does not include correspondence, internal memos, and the like. The annual reports show not only the growth of the company throughout its existence but also the changing way it portrayed itself to investors and other interested parties. News clippings document the way in which the company, its finances, and its products were viewed. Materials such as marketing brochures and slide programs show the way in which the company sold its products and spread the word about its science. Finally, a stock prospectus and the merger prospectus shed light on the finances of the corporation.
Several items in the collection require explanation:
Restrictions on Access :
The collection is open to the public by appointment.Restrictions on Use :
The Museum of History & Industry is the owner of the materials in the Sophie Frye Bass Library and makes available reproductions for research, publication, and other uses. Written permission must be obtained from MOHAI before any reproduction use. The museum does not necessarily hold copyright to all of the materials in the collections. In some cases, permission for use may require seeking additional authorization from the copyright owners.Preferred Citation :
Immunex Corporation Collection, Museum of History & Industry, Seattle
Acquisition Information :
Amgen and former Immunex employees donated the records to the museum in 2003.Processing Note :
Processed by Julie Kerssen in 2003.Separated Materials :
These materials are part of a donation that also included a number of artifacts. These artifacts are cataloged and stored separately by MOHAI's Collections Department.
Detailed Description of the Collection